Small Molecules
5 May 2017
Zafgen Announces Positive Topline Phase 1 Data for ZGN-1061, a Second Generation MetAP2 Inhibitor3 May 2017
Can-Fite’s Liver Protective Drug Namodenoson Enters Phase II Trial for Treatment of NAFLD/NASH29 April 2017
Galapagos presents pre-clinical data with selective ADAMTS-5 inhibitor GLPG1972 for osteoarthritis at OARSI28 April 2017
Sage Therapeutics Announces Initiation of Phase 1 Development and First Dosing of SAGE-718News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports